Latest Orphai Therapeutics News & Updates

See the latest news and media coverage for Orphai Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orphai Therapeutics

Biotechnology company developing inhaled treatments for serious pulmonary diseases

orphai-therapeutics.com
Headquarters
New Haven, United States
Founded year
2013
Company type
Private company
Number of employees
2–20
Industry
Pharmaceuticals

Last updated

Latest news about Orphai Therapeutics

In short: Orphai Therapeutics was acquired by Quince Therapeutics to advance its pulmonary drug pipeline following positive Phase 2 clinical data.

Company announcements

Orphai Therapeutics

Orphai Therapeutics’ Phase 2a LAM-001 selected for ATS 2026 presentation

Results from the multicenter open-label study of LAM-001 as add-on therapy in pulmonary hypertension patients will be presented orally at the conference in Orlando.

Unlock all announcements with a

Media coverage

Yahoo Finance

OrphAI Therapeutics receives Orphan Drug Designation for AIT-101 as a treatment for amyotrophic lateral sclerosis in the European Union

GUILFORD, Conn., Feb. 15, 2024 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. ("OrphAI"), a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today that...

Unlock all articles with a

Never miss news about Orphai Therapeutics

Track Orphai Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orphai Therapeutics competitors & trending companies

Browse news for competitors to Orphai Therapeutics and other trending companies.